Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study

Interferon-y Release Assays (IGRA) reversions have been reported in different clinical scenarios for the diagnosis of tuberculosis (TB) infection. This study aimed to determine the rate of QuantiFERON-TB Gold Plus (QFT-Plus) reversions during contact investigation as a potential strategy to reduce t...

Descripción completa

Detalles Bibliográficos
Autores: Pérez-Recio, Sandra, Grijota-Camino, Maria D, Anibarro, Luis, Rabuñal-Rey, Ramón, Sabria, Josefina, Gijón-Vidaurreta, Paloma, Pomar, Virginia, García-Gasalla, Mercedes, Domínguez-Castellano, Ángel, Trigo, Matilde, Santos, María Jesús, Cebollero, Alba, Rodríguez, Sara, Moga, Esther, Penas-Truque, Anton, Martos, Carmen, Ruiz-Serrano, M Jesús, Garcia-de-Cara, Erika I, Alcaide Matas, Fernando, Santin, Miguel
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositorio:Docusalut
Idioma:inglés
OAI Identifier:oai:docusalut.com:20.500.13003/19966
Acceso en línea:https://hdl.handle.net/20.500.13003/19966
Access Level:acceso abierto
Palabra clave:Prospective Studies
Adult
Tuberculosis
Tuberculosis, Pulmonary
Humans
Cohort Studies
Latent Tuberculosis
Tuberculosis Latente
Tuberculosis Pulmonar
Estudios de Cohortes
Humanos
Estudios Prospectivos
Adulto
Descripción
Sumario:Interferon-y Release Assays (IGRA) reversions have been reported in different clinical scenarios for the diagnosis of tuberculosis (TB) infection. This study aimed to determine the rate of QuantiFERON-TB Gold Plus (QFT-Plus) reversions during contact investigation as a potential strategy to reduce the number of preventive treatments. Prospective, multicentre cohort study of immunocompetent adult contacts of patients with pulmonary TB tested with QFT-Plus. Contacts with an initial positive QFT-Plus (QFT-i) underwent a second test within 4 weeks (QFT-1), and if negative, underwent a repeat test 4 weeks later (QFT-2). Based on the QFT-2 result, we classified cases as sustained reversion if they remained negative and as temporary reversion if they turned positive. We included 415 contacts, of whom 96 (23.1%) had an initial positive test (QFT-i). Following this, 10 had negative QFT-1 results and 4 (4.2%) of these persisted with a negative result in the QFT-2 (sustained reversions). All four sustained reversions occurred in contacts with IFN-γ concentrations between ≥0.35 and ≤0.99 IU•mL-1 in one or both QFT-i tubes. In this study, TB contact investigations rarely reveal QFT-Plus reversion. These results do not support retesting cases with an initial positive result to reduce the number of preventive treatments.

Similares en LA Referencia